Adverse Drug Reactions

New Version of Devices to Treat Clogged Neck Arteries Approved by U.S. Food and Drug Administration

Published in Physician Law Weekly, March 7th, 2007

The Cordis Endovascular Division of Cordis Corporation, announced U.S. Food and Drug Administration (FDA) approval to market its PRECISE(R) RX Nitinol Self-Expanding Stent and ANGIOGUARD(R) RX Emboli Capture Guidewire System to treat clogged neck arteries. Approval of the Cordis carotid system was announced at the Arizona Heart Institute's International Congress on Endovascular Interventions in Scottsdale, Arizona.

The PRECISE(R) RX Nitinol Self-Expanding Stent and ANGIOGUARD(R) RX Emboli Capture Guidewire System are different from Cordis' over-the-wire carotid system approved last year. The RX, or rapid exchange, version facilitates single operator use and more...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2007-03-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry